It is an implant for treating ocular surface disorders that can replace the amnion, the only treatment material for corneal disorders patients.
There is no product that can replace the amnion among the products currently being sold.
Amnion is difficult to obtain as a human derived materials, but almost the only cure for eye surface disease that has been revealed so far.
However, since it is a human derived materials, there should be donations from donors and has various problems such as the risk of infection.
Amnion is a thin layer of biological membrane that forms the placenta, consisting of cuboidal epithelial cell layer, basement membrane, and epilepsy layer which has been in use since the 1970s.
Amnion secretes various growth factors that inhibit inflammatoty cytokiness with efficacy and reduce the erosion of inflammatory cells to promote regeneration to epithelial cells to relieve pain.
In addition, it has antibacterial properties that promote healing of wounds and reduce the amount of scars.
Amnion has long been used for treatment of ocular trauma and various ocular surface disorders and for reconstructive operation of ocular surface.
- EYE-Cure used by professional medical professionals and is not available to the public.
- This product can be applied to the operation of the ocular and there are 5 packs of parcels inserted in one box.
- It is used directly to the surface of the eyeball after hydration.
- EYE-Cure is fixed to the conjunctiva, episclera, and deficit site through a surgical method similar to the amnion, which acts as a deterrent against excessive cicatrix by filling tissue defects or forming space in the subconjunctiva.